V007-4103 Screening compound: 2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

V007-4103 Screening compound: 2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole
V007-4103 Screening compound: 2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound V007-4103
2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V007-4103

Molecular Formula

C27H36N4O5S2 (C27 H36 N4 O5 S2)

Compound Name

2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazole

IUPAC name

2-{[(4-ethoxyphenyl)methyl]sulfanyl}-1-[3-(morpholin-4-yl)propyl]-5-(morpholine-4-sulfonyl)-1H-13-benzodiazole

SMILES

CCOc1ccc(CSc2nc(cc(cc3)S(N4CCOCC4)(=O)=O)c3n2CCCN2CCOCC2)cc1

InChI

InChI=1S/C27H36N4O5S2/c1-2-36-23-6-4-22(5-7-23)21-37-27-28-25-20-24(38(32,33)30-14-18-35-19-15-30)8-9-26(25)31(27)11-3-10-29-12-16-34-17-13-29/h4-9,20H,2-3,10-19,21H2,1H3

InChI Key

YRPANRQQKQJYFY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19960127

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

560.74

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.358

Distribution Coefficient, logD

3.213

Water Solubility, LogSw

-3.52

Polar Surface Area

69.090

Acid Dissociation Constant (pKa)

24.63

Base Dissociation Constant (pKb)

7.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

51.90

V007-4103 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V007-4103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V007-4103?
Check Price and Availability of V007-4103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V007-4103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V007-4103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V007-4103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V007-4103 available by request